Abilify and Calcium acetate drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Abilify (aripiprazole) and Calcium acetate (calcium acetate). Common drug interactions include bone pain among females and schizophrenia among males.

The phase IV clinical study analyzes what interactions people have when they take Abilify and Calcium acetate. It is created by eHealthMe based on reports of 15 people who take the same drugs from the FDA, and is updated regularly.

What is Abilify?

Abilify has active ingredients of aripiprazole. It is often used in depression. eHealthMe is studying from 101,454 Abilify users. Check the latest studies of Abilify.

What is Calcium acetate?

Calcium acetate has active ingredients of calcium acetate. It is often used in osteoporosis. eHealthMe is studying from 3,076 Calcium acetate users. Check the latest studies of Calcium acetate.



On Jul, 19, 2026

15 people who take Abilify and Calcium acetate together, and have interactions are studied.

Abilify and Calcium acetate drug interactions.

What are the common drug interactions of Abilify and Calcium Acetate, by gender? *:

female:

  1. Bone pain
  2. Cardiac arrest
  3. Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
  4. Flushing (the warm, red condition of human skin)
  5. Hypoxic-ischaemic encephalopathy (a condition that occurs when the entire brain is deprived of an adequate oxygen supply, but the deprivation isn't total)
  6. Injection site haematoma (localized swelling filled with blood at injection site)
  7. Injection site pain
  8. Lung transplant
  9. Lung transplant rejection (failure of lung transplant)
  10. Pain

male:

  1. Schizophrenia (a mental disorder characterized by a breakdown of thought processes)
  2. Abdominal pain
  3. Bundle branch block right (absence of transmission of electric impulses from the atrioventricular (av) bundle of his to the right ventricle)
  4. Cardiomegaly (increased size of heart than normal)
  5. Cellulitis (infection under the skin)
  6. Chest pain
  7. Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
  8. Cognitive disorder (mental health disorders affects learning, memory, perception, and problem solving)
  9. Confusional state
  10. Contusion (a type of hematoma of tissue in which capillaries)

What are the common drug interactions of Abilify and Calcium Acetate, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

  1. Upper limb fracture
  2. Weight increased
  3. Bone pain
  4. Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
  5. Dizziness
  6. Fall
  7. Flushing (the warm, red condition of human skin)
  8. Injection site haematoma (localized swelling filled with blood at injection site)
  9. Injection site pain
  10. Myalgia (muscle pain)

60+:

  1. Disability
  2. Myalgia (muscle pain)
  3. Appendicitis (inflammation of the appendix)
  4. Arthralgia (joint pain)
  5. Back disorder
  6. Back pain
  7. Basal cell carcinoma (a skin cancer, it rarely metastasizes or kills)
  8. Bone neoplasm malignant (cancer of bone)
  9. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  10. Bundle branch block right (absence of transmission of electric impulses from the atrioventricular (av) bundle of his to the right ventricle)

What are the existing conditions these people have? *

  1. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 5 people, 33.33%
  2. Cataplexy (loss of muscle tone accompanied by full conscious awareness): 5 people, 33.33%
  3. Drowsiness: 5 people, 33.33%
  4. Infection: 2 people, 13.33%
  5. Schizophrenia (a mental disorder characterized by a breakdown of thought processes): 2 people, 13.33%
  6. High Blood Pressure: 2 people, 13.33%
  7. Hypersensitivity: 2 people, 13.33%
  8. Multiple Myeloma (cancer of the plasma cells): 2 people, 13.33%
  9. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 1 person, 6.67%
  10. Hyperlipidaemia (presence of excess lipids in the blood): 1 person, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Abilify and Calcium acetate?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Abilify and Calcium acetate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Abilify:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Calcium acetate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Abilify and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Calcium acetate and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on aripiprazole and calcium acetate (the active ingredients of Abilify and Calcium acetate, respectively), and Abilify and Calcium acetate (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: